---
title: "High Tide Inc. (HITI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HITI.US.md"
symbol: "HITI.US"
name: "High Tide Inc."
industry: "Pharmaceuticals"
datetime: "2026-06-16T10:47:30.701Z"
locales:
  - [en](https://longbridge.com/en/quote/HITI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HITI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HITI.US.md)
---

# High Tide Inc. (HITI.US)

## Company Overview

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.hightideinc.com](https://www.hightideinc.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-16T04:30:14.000Z

**Overall: C (0.51)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 85 / 197 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 18.98% |  |
| Net Profit YoY | -596.26% |  |
| P/B Ratio | 3.05 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 197770180.50 |  |
| Revenue | 456240094.49 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -40.44% | E |
| Profit Margin | -7.42% | D |
| Gross Margin | 24.90% | C |
| Revenue YoY | 18.98% | B |
| Net Profit YoY | -596.26% | E |
| Total Assets YoY | 56.39% | A |
| Net Assets YoY | -25.22% | E |
| Cash Flow Margin | -62.15% | E |
| OCF YoY | 18.98% | B |
| Turnover | 2.16 | A |
| Gearing Ratio | 70.56% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - High Tide Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "18.98%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-596.26%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.05",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "197770180.50",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "456240094.49",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-40.44%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-7.42%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "24.90%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "18.98%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-596.26%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "56.39%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-25.22%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-62.15%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "18.98%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "2.16",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "70.56%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -5.84 | 171/197 | - | - | - |
| PB | 3.05 | 114/197 | 3.24 | 2.80 | 2.14 |
| PS (TTM) | 0.43 | 16/197 | 0.66 | 0.51 | 0.46 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-15T04:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 71% |
| Overweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.25 |
| Highest Target | 7.00 |
| Lowest Target | 5.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/HITI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/HITI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/HITI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/HITI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**